Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies

PURPOSE: To explore the role of plasmatic platelet-activating factor acetylhydrolase (PAF-AH), a marker of cardiovascular risk, in patients with anti-phospholipid antibodies (aPL). METHODS: PAF-AH activity was assessed in a series of 167 unselected patients screened for aPL in a context of thromboti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Auto Immun Highlights
Päätekijät: Fabris, Martina, Cifù, Adriana, Pistis, Cinzia, Siega-Ducaton, Massimo, Fontana, Desrè Ethel, Giacomello, Roberta, Tonutti, Elio, Curcio, Francesco
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5365449/
https://ncbi.nlm.nih.gov/pubmed/28341873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13317-017-0092-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia